Clinical trial
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
NCT02490904 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- October 19, 2016
- Completion date
- August 31, 2031
- Enrollment
- 132 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease